PubMed
Nucleotide
Protein
Genome
Structure
PopSet
Taxonomy
OMIM
OMIM Update List for March, 1996
Please send your questions to the
NCBI Help Desk
.
March 31, 1996
New Entries:
601167
PURINERGIC RECEPTOR P2Y, G-PROTEIN COUPLED, 1; P2RY1
Changed Entries:
100500
ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER
126600
DOYNE HONEYCOMB DEGENERATION OF RETINA; DHD
133171
ERYTHROPOIETIN RECEPTOR; EPOR
160900
DYSTROPHIA MYOTONICA; DM
174050
POLYCYSTIC LIVER DISEASE; PLD
235400
HEMOLYTIC-UREMIC SYNDROME; HUS
305900
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
306700
HEMOPHILIA A
600041
PURINERGIC RECEPTOR P2Y, G-PROTEIN COUPLED, 2; P2RY2
March 30, 1996
Changed Entries:
134797
FIBRILLIN-1; FBN1
141900
HEMOGLOBIN--BETA LOCUS; HBB
175100
ADENOMATOUS POLYPOSIS OF THE COLON; APC
176270
PRADER-WILLI SYNDROME; PWS
176860
PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
191170
TUMOR PROTEIN p53; TP53
245349
LACTIC ACIDEMIA DUE TO DEFECT IN THE X-LIPOYL CONTAINING COMPONENT
261600
PHENYLKETONURIA; PKU1
262890
PLATELET RECEPTOR FOR FACTOR X, DEFICIENCY OF
266200
PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE
306700
HEMOPHILIA A
306900
HEMOPHILIA B; HEMB
313700
TESTICULAR FEMINIZATION SYNDROME; TFM
516003
COMPLEX I, SUBUNIT ND4; MTND4
March 29, 1996
New Entries:
601168
UNC-33-LIKE PHOSPHOPROTEIN
Changed Entries:
107580
TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
120150
COLLAGEN, TYPE I, ALPHA-1 CHAIN; COL1A1
120330
COLOBOMA OF OPTIC NERVE WITH RENAL DISEASE
134820
FIBRINOGEN--ALPHA POLYPEPTIDE CHAIN; FGA
151385
CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2
154700
MARFAN SYNDROME; MFS
163260
NUCLEAR FACTOR ERYTHROID-2-LIKE 1; NFE2L1
208530
ASPLENIA WITH CARDIOVASCULAR ANOMALIES
211970
CAMPOMELIC DYSPLASIA; CMD1
234200
HALLERVORDEN-SPATZ DISEASE
258865
ORAL-FACIAL-DIGITAL SYNDROME WITH RETINAL ABNORMALITIES
266600
REGIONAL ENTERITIS
273300
TESTICULAR TUMORS
300037
GLYPICAN-3; GPC3
600284
ELL GENE; ELL
600284
ELL GENE; ELL
600300
SOLUTE CARRIER FAMILY 1, MEMBER 2; SLC1A2
600300
SOLUTE CARRIER FAMILY 1, MEMBER 2; SLC1A2
600845
P2X RECEPTOR, SUBUNIT 1; P2X1
600990
LAGOPHTHALMIA WITH BILATERAL CLEFT LIP AND PALATE
601047
CAVEOLIN-1; CAV; CAV1
601059
ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR
601070
INTERLEUKIN-15 RECEPTOR, ALPHA; IL15RA
601083
CD4/CD8 T-CELL RATIO
601095
HARROD SYNDROME
601101
OSLER-RENDU-WEBER SYNDROME 3; ORW3
601146
CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 1; CDMP1
601157
DEFENSIN 4, CORTICOSTATIN; DEF4
March 28, 1996
New Entries:
300044
TRANSKETOLASE-2; TKT2
601160
LISSENCEPHALY SYNDROME TYPE III
601161
TRISOMY 18-LIKE SYNDROME
601162
CATARACTS WITH MOTOR NEURONOPATHY, SHORT STATURE, AND SKELETAL ABNORMALITIES
601163
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS
601164
EXTRAPYRAMIDAL DISORDER, PROGRESSIVE, WITH PRIMARY HYPOGONADISM AND
601165
CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,
601166
G-PROTEIN-COUPLED RECEPTOR 15; GPR15
Changed Entries:
106150
ANGIOTENSIN I; AGT
113811
COLLAGEN, TYPE XVII, ALPHA-1 POLYPEPTIDE; COL17A1
126700
DRUSEN OF BRUCH MEMBRANE
158340
MUCIN 1, URINARY; MUC1
179508
RAB1, MEMBER RAS ONCOGENE FAMILY; RAB1
186730
T-CELL GLYCOPROTEIN CD8B; CD8B
188395
THYMOSIN-BETA-4; TMSB4
190198
NOTCH (DROSOPHILA) HOMOLOG 1; NOTCH1
190198
NOTCH (DROSOPHILA) HOMOLOG 1; NOTCH1
270550
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE
277730
WERNICKE-KORSAKOFF SYNDROME
300100
ADRENOLEUKODYSTROPHY; ALD
600381
CG-1 ANTIGEN; CG1
600443
GLUTAREDOXIN; GLRX
600823
PROTEASE, SERINE, 8; PRSS8
600827
PHOSPHODIESTERASE 6C, cGMP-SPECIFIC, CONE, ALPHA PRIME; PDE6C
600835
STROMAL CELL-DERIVED FACTOR 1; SDF1
600853
HEPARAN SULFATE-N-DEACETYLASE/N-SULFOTRANSFERASE; HSST
600853
HEPARAN SULFATE-N-DEACETYLASE/N-SULFOTRANSFERASE; HSST
600859
JTV1 GENE
600860
GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A
600863
CASEIN KINASE 1, EPSILON; CSNK1E
600864
CASEIN KINASE 1, DELTA; CSNK1D
600881
CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS
600897
GAP JUNCTION PROTEIN, ALPHA-8, 50 kD; GJA8
March 27, 1996
New Entries:
601156
EOTAXIN
601159
CHEMOKINE (C-C) RECEPTOR 1; CMKBR1
Changed Entries:
109150
AZOREAN NEUROLOGIC DISEASE
118661
CHONDROITIN SULFATE PROTEOGLYCAN 2; CSPG2
120435
COLON CANCER, FAMILIAL, NONPOLYPOSIS TYPE 1; FCC1
125370
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
126452
DOPAMINE RECEPTOR D4; DRD4
137241
GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR
143100
HUNTINGTON DISEASE; HD
145500
HYPERTENSION, ESSENTIAL
151400
LEUKEMIA, CHRONIC LYMPHATIC; CLL
159440
MYELIN PROTEIN ZERO; MPZ
160980
MYXOMA, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY
165370
APLYSIA RAS-RELATED HOMOLOG 6; ARH6
167771
PANCREATIC STONE PROTEIN, SECRETORY, 2; PSPS2
168461
CYCLIN D1; CCND1
217030
COMPLEMENT COMPONENT-3 INACTIVATOR, DEFICIENCY OF
222900
DISACCHARIDE INTOLERANCE I
227645
FANCONI ANEMIA, COMPLEMENTATION GROUP C; FACC
264480
PSEUDOTRISOMY 13 SYNDROME
300028
U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
309860
MONOAMINE OXIDASE B; MAOB
311250
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600108
MATRIX METALLOPROTEINASE-13; MMP13
600846
P2X RECEPTOR, SUBUNIT 4; P2X4
600879
NUCLEAR RESPIRATORY FACTOR 1; NRF1
601075
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION
601079
U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
601080
U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT
601123
SIALYLTRANSFERASE 8; SIAT8
601150
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 11; DDX11
601151
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 12; DDX12
March 26, 1996
New Entries:
601157
DEFENSIN 4, CORTICOSTATIN; DEF4
601158
C-JUN KINASE; JNK1
Changed Entries:
104614
SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
104614
SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
104614
SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
109150
AZOREAN NEUROLOGIC DISEASE
111700
BLOOD GROUP--RHESUS SYSTEM Cc/Ee POLYPEPTIDES; RHC; RHE; RHCE
114000
CAFFEY DISEASE
118945
CILIARY NEUROTROPHIC FACTOR; CNTF
118946
CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR
122560
CORTICOTROPIN-RELEASING HORMONE; CRH
125370
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
134920
FIBROBLAST GROWTH FACTOR-2; FGF2
137800
GLIOMA OF BRAIN
143100
HUNTINGTON DISEASE; HD
143100
HUNTINGTON DISEASE; HD
143100
HUNTINGTON DISEASE; HD
143100
HUNTINGTON DISEASE; HD
148067
KERATIN 16; KRT16; K16
148820
KLEIN-WAARDENBURG SYNDROME
158000
MONILETHRIX
159595
MYELOPROLIFERATIVE SYNDROME, TRANSIENT
160900
DYSTROPHIA MYOTONICA; DM
161800
NEMALINE MYOPATHY
161950
NEPHRITIS, IgA TYPE
164400
OLIVOPONTOCEREBELLAR ATROPHY I; OPCA I
165120
V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN
165160
V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN
174900
POLYPOSIS COLI, JUVENILE TYPE
176807
PROSTATE CANCER; PRCA1
176876
PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, 11; PTPN11
180646
RNA, SMALL NUCLEOLAR E2; RNE2
180849
RUBINSTEIN SYNDROME
182870
SPECTRIN, BETA SUBUNIT; SPTB
182920
SPHEROID BODY MYOPATHY
186770
T-CELL LEUKEMIA-3; TCL3
188070
THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R
191090
TUBEROUS SCLEROSIS-4; TSC4
193300
VON HIPPEL-LINDAU SYNDROME; VHL
210900
BLOOM SYNDROME; BLM
216360
COACH SYNDROME
220290
DEAFNESS, NEUROSENSORY AUTOSOMAL RECESSIVE, 1; DFNB1
230400
GALACTOSEMIA
231670
GLUTARICACIDEMIA I
231680
GLUTARICACIDURIA IIA; GA IIA
232400
GLYCOGEN STORAGE DISEASE III
232400
GLYCOGEN STORAGE DISEASE III
232500
GLYCOGEN STORAGE DISEASE IV
246400
LETTERER-SIWE DISEASE
254770
MYOCLONIC EPILEPSY, JUVENILE; EJM1; EJM; JME
263520
POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
267700
RETICULOSIS, FAMILIAL HISTIOCYTIC
267700
RETICULOSIS, FAMILIAL HISTIOCYTIC
300700
ALBINISM-DEAFNESS SYNDROME; ADFN; ALDS
308000
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE; HPRT; HGPRT
309400
MENKES SYNDROME
309548
FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA (X)(Q28); FRAXE
309548
FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA(X)(q28); FRAXE
309550
FRAGILE SITE, FOLIC ACID TYPE, RARE, FRA(X)(q27.3)
600353
S100 CALCIUM-BINDING PROTEIN A7; S100A7
600471
DEFENSIN 6; DEF6
600472
DEFENSIN 5; DEF5
600542
CHONDROSARCOMA, MYXOID EXTRASKELETAL, FUSED TO EWS; CSMF
600674
MICROTIA-ANOTIA
600722
PALMITOYL-PROTEIN THIOESTERASE; PPT
600837
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GDNF
600936
HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR
600939
INTERLEUKIN-11 RECEPTOR, ALPHA; IL11RA
600947
HUNTINGTIN-ASSOCIATED PROTEIN; HAP1
600959
BETA COAT PROTEIN; COPB
600968
NA-CL COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT
600978
TUMOR NECROSIS FACTOR C; TNFC
600979
TUMOR NECROSIS FACTOR C RECEPTOR; TNFCR
601009
TIGHT JUNCTION PROTEIN 1; TJP1
601010
TRANSCRIPTION FACTOR-15; TCF15
601014
DISCS, LARGE (DROSOPHILA) HOMOLOG 1; DLG1
601023
VALOSIN-CONTAINING PROTEIN; VCP
601024
CLATHRIN ADAPTOR PROTEIN 50; CLAPM1
601026
CLATHRIN ADAPTOR PROTEIN, ALPHA SUBUNIT; CLAPA1
601029
PATERNALLY EXPRESSED GENE 3; PEG3
601031
RHOPHILIN
601032
SERINE-THREONINE PROTEIN KINASE N; PKN
601068
MYOCLONUS EPILEPSY, BENIGN ADULT FAMILIAL; MEBA
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
601120
CADHERIN-5; CDH5
601120
CADHERIN-5; CDH5
601128
H3 HISTONE, FAMILY 3A; H3F3A
601144
RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION AND SUDDEN DEATH,
601149
ISOCITRATE DEHYDROGENASE 3 (NAD+) ALPHA; IDH3A
March 25, 1996
New Entries:
300042
ALOPECIA, CONGENITAL
300043
HEPATOMA-DERIVED GROWTH FACTOR; HDGF
601144
RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION AND SUDDEN DEATH,
601146
CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 1; CDMP1
601147
CARTILAGE-DERIVED MORPHOGENETIC PROTEIN 2; CDMP2
601148
MITOCHONDRIAL CAPSULE SELENOPROTEIN; MCSP
601149
ISOCITRATE DEHYDROGENASE 3 (NAD+) ALPHA; IDH3A
601150
CHL1-RELATED HELICASE GENE-1; CHLR1
601151
CHL1-RELATED HELICASE GENE-2; CHLR2
601153
FRAGILE HISTIDINE TRIAD GENE; FHIT
601155
MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HA1
Changed Entries:
104311
ALZHEIMER DISEASE, FAMILIAL, TYPE 3; AD3
107400
PROTEASE INHIBITOR 1 (ANTI-ELASTASE), ALPHA-1-ANTITRYPSIN; PI
118504
CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
123837
CYCLIN E; CCNE
123838
CYCLIN C; CCNC
124010
CYTOCHROME P-450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4
124060
CYTOCHROME P-450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2
138319
GLUTATHIONE PEROXIDASE-2; GPX2
142410
TRANSCRIPTION FACTOR 1, HEPATIC; TCF1
144700
HYPERNEPHROMA
147650
ISOCITRIC DEHYDROGENASE 2 (NADP+), MITOCHONDRIAL; IDH2
147700
ISOCITRIC DEHYDROGENASE 1 (NADP+), SOLUBLE; IDH1
153330
LYSOSOME-ASSOCIATED MEMBRANE PROTEIN A; LAMP1
163800
NODAL RHYTHM
173445
PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE; PECAM1
173900
POLYCYSTIC KIDNEYS
176860
PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
176886
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR TYPE, GAMMA POLYPEPTIDE; PTPRG
177735
PSEUDOHYPOALDOSTERONISM, TYPE I
201250
ACROMESOMELIC DWARFISM
235200
HEMOCHROMATOSIS; HFE
264350
PSEUDOHYPOALDOSTERONISM, TYPE I; PHA1
300019
HOST CELL FACTOR C1; HCFC1
310300
MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES
600022
PROSTAGLANDIN I2 RECEPTOR; PTGIR
600228
SODIUM CHANNEL, NONVOLTAGE-GATED, 1; SCNN1A
600339
MOVED TO 300043
600436
GLUTATHIONE-S-TRANSFERASE THETA 1; GSTT1
600478
SUPERKILLER VIRALICIDIC ACTIVITY 2; SKIV2
600563
PROSTAGLANDIN F RECEPTOR (FP); PTGFR
600633
TREFOIL FACTOR 3, INTESTINAL; TFF3
600642
MINOR HISTOCOMPATIBILITY ANTIGEN HA-2; HA2
600760
SODIUM CHANNEL, NONVOLTAGE-GATED 1 BETA; SCNN1B
600865
NEUROENDOCRINE-SPECIFIC PROTEIN; NSP
600897
GAP JUNCTION PROTEIN, ALPHA-8, 50 kD; GJA8
601036
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H-PRIME; HNRPH2
601151
CHL1-RELATED HELICASE GENE-2; CHLR2
Clinical Synopsis for
600542
CHONDROSARCOMA, MYXOID EXTRASKELETAL, FUSED TO EWS; CSMF
March 22, 1996
New Entries:
601152
PERIPHERAL NEUROPATHY AND OPTIC ATROPHY
601154
CARDIOMYOPATHY, FAMILIAL DILATED, 2; CMPD2
Changed Entries:
109270
SOLUTE CARRIER FAMILY 4, ANION EXCHANGER, MEMBER 1; SLC4A1
115200
CARDIOMYOPATHY, FAMILIAL IDIOPATHIC
118200
CHARCOT-MARIE-TOOTH DISEASE 1B; CMT1B
118210
CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118210
CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
120360
MATRIX METALLOPROTEINASE-2; MMP2
160900
DYSTROPHIA MYOTONICA; DM
266500
REFSUM DISEASE
266500
REFSUM DISEASE
300300
BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
600049
MYELODYSPLASIA SYNDROME-ASSOCIATED SEQUENCE-1
600884
CARDIOMYOPATHY, FAMILIAL DILATED
March 21, 1996
New Entries:
601133
CYTOCHROME P450, SUBFAMILY IIG, OLFACTORY-SPECIFIC; CYP2G1
601141
POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; KCNA1B
601142
POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; KCNA2B
601143
DYNACTIN 1; DCTN1
601145
CYSTATIN B; CST6
Changed Entries:
105150
AMYLOIDOSIS VI
114208
CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL
115197
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
125480
MANIC-DEPRESSIVE PSYCHOSIS, AUTOSOMAL
134797
FIBRILLIN-1; FBN1
141900
HEMOGLOBIN--BETA LOCUS; HBB
142230
HEMOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34
142360
HEPARIN COFACTOR II DEFICIENCY
145500
HYPERTENSION, ESSENTIAL
156790
MICROFIBRIL-ASSOCIATED PROTEIN 2; MFAP2
159440
MYELIN PROTEIN ZERO; MPZ
164740
V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E2 ONCOGENE HOMOLOG 2; ETS2
167800
PANCREATITIS, HEREDITARY
172410
PHOSPHOLIPASE A2, GROUP IB; PLA2G1B
180849
RUBINSTEIN SYNDROME
191170
TUMOR PROTEIN p53; TP53
216411
COCKAYNE SYNDROME, TYPE III
230400
GALACTOSEMIA
234200
HALLERVORDEN-SPATZ DISEASE
237500
HYPERBILIRUBINEMIA II
252100
MOHR SYNDROME
254800
MYOCLONUS EPILEPSY OF UNVERRICHT AND LUNDBORG
260490
PANOSTOTIC FIBROUS DYSPLASIA
263200
POLYCYSTIC KIDNEY AND HEPATIC DISEASE-1; PKHD1
308800
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI; KFSD
309200
MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED
410000
AMELOGENIN, Y-CHROMOSOMAL; AMELY
600119
ADHALIN; ADL
600595
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE, MOUSE TG737, HUMAN
600658
PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C
600698
HIGH MOBILITY GROUP PROTEIN HMGI-C; HMGIC
600837
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GDNF
600887
MutS HUMAN HOMOLOG 3; MSH3
601103
MICROFIBRIL-ASSOCIATED GLYCOPROTEIN 2; MAGP2
March 20, 1996
New Entries:
300041
GUANYLYL CYCLASE 2F, RETINAL; GUC2F
601134
INTEGRAL MEMBRANE PROTEIN 1; IGM1
601135
GASTRULATION AND BRAIN SPECIFIC-2; GBX2
601136
TRANSSUPPRESSOR OF EXPRESSION-2; TSE2
601137
GUANYLYL CYCLASE, MEMBRANE, TYPE D; GUCY2D
601138
GUANYLYL CYCLASE, MEMBRANE, TYPE E; GUCY2E
601139
ZINC FINGER PROTEIN OTK18
601140
PHOSPHOLIPASE C-BETA-3 NEIGHBORING GENE; PNG
Changed Entries:
139313
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA SUBUNIT (Gq CLASS); GNA11
158375
MUCIN 7, SALIVARY; MUC7
173350
PLASMINOGEN; PLG
235200
HEMOCHROMATOSIS; HFE
600179
GUANYLATE CYCLASE 2D, RETINAL; GUC2D
600678
G/T MISMATCH-BINDING PROTEIN; GTBP
600692
TROPONIN-T3, FAST SKELETAL; TNNT3
600821
ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A
600926
PROTEIN TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE
600926
PROTEIN TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE
601136
TRANSSUPPRESSOR OF EXPRESSION-2; TSE2
March 19, 1996
New Entries:
601132
KINASE SUPPRESSOR OF RAS; KSR
Changed Entries:
125370
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
138400
GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPD
143100
HUNTINGTON DISEASE; HD
173350
PLASMINOGEN; PLG
173350
PLASMINOGEN; PLG
600673
UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF
601128
H3 HISTONE, FAMILY 3A; H3F3A
March 18, 1996
New Entries:
601114
DISCS, LARGE (DROSOPHILA) HOMOLOG 3; DLG3
601115
GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3
601116
GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8
601117
THIMET OLIGOPEPTIDASE 1; THOP1
601118
CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG
601128
NEW ENTRY: H3F3A, Histone type 3A
601129
CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8
601130
CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
601131
CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18
Changed Entries:
107580
TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
107580
TRANSCRIPTION FACTOR AP-2, ALPHA; TFAP2A
107970
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
124020
CYTOCHROME P-450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
130500
ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41
137025
FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN
162642
NEUROPEPTIDE Y Y2 RECEPTOR; NPY2R
164940
GARDNER-RASHEED FELINE SARCOMA VIRAL (V-FGR) ONCOGENE; FGR
190090
V-SRC AVIAN SARCOMA (SCHMIDT-RUPPIN A-2) VIRAL ONCOGENE; SRC
305360
MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1
600267
PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, 13; PTPN13
600673
UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF
600944
DEOXYHYPUSINE SYNTHASE; DHPS
March 15, 1996
Changed Entries:
104614
SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
120140
COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
120140
COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
125480
MAJOR AFFECTIVE DISORDER 1; MAFD1
125480
MANIC-DEPRESSIVE PSYCHOSIS, AUTOSOMAL
137295
GATA-BINDING PROTEIN 2; GATA2
143100
HUNTINGTON DISEASE; HD
150310
LAMININ, BETA 3; LAMB3
151385
CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2
154700
MARFAN SYNDROME; MFS
156845
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
165215
ECTROPIC VIRAL INTEGRATION SITE-1; EVI1
180474
RIBOSOMAL PROTEIN L22; RPL22
191092
TUBEROUS SCLEROSIS-2; TSC2
220100
CYSTINURIA; CSNU
220110
CYTOCHROME-c-OXIDASE DEFICIENCY
226700
EPIDERMOLYSIS BULLOSA LETALIS
232300
GLYCOGEN STORAGE DISEASE II
305371
GATA-BINDING PROTEIN 1; GATA1
305900
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
309200
MAJOR AFFECTIVE DISORDER 2; MAFD2
309200
MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED
309548
MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;
600049
MYELODYSPLASIA SYNDROME-ASSOCIATED SEQUENCE-1
600918
CYSTINURIA, TYPE III; CSNU3
601121
PLACENTAL GROWTH FACTOR; PGF
March 14, 1996
New Entries:
300039
POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
300040
SEGREGATION OF MITOTIC CHROMOSOMES, 1; SMC1;
601126
TATA ELEMENT MODULATORY FACTOR 1; TMF1
601127
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION
Clinical Synopsis for
300039
POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
Changed Entries:
106180
ANGIOTENSIN I CONVERTING ENZYME; ACE; ACE1
109400
BASAL CELL NEVUS SYNDROME; BCNS
111400
BLOOD GROUP--P SYSTEM
117550
CEREBRAL GIGANTISM
123812
CYCLIC-AMP-RESPONSE-ELEMENT MODULATOR; CREM
125480
DEPRESSIVE DISORDER
142925
HLA-H HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLAH
152790
LUTEINIZING HORMONE-CHORIOGONADOTROPIN RECEPTOR; LHCGR
157975
MOVED TO 172411
164905
ONCOGENE RCK; RCK
172411
PHOSPHOLIPASE A2, GROUP 2A; PLA2G2A
172411
PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A
175200
POLYPOSIS, HAMARTOMATOUS INTESTINAL
217095
CONOTRUNCAL HEART MALFORMATIONS; CTHM
222400
DIAPHRAGM, UNILATERAL AGENESIS OF
263520
POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II
264480
PSEUDOTRISOMY 13 SYNDROME
276903
MYOSIN VIIA; MYO7A
300039
POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4
300040
SEGREGATION OF MITOTIC CHROMOSOMES, 1; SMC1
304400
DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION
309550
MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28
310300
MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES
314690
XE169 GENE; XE169;
600420
MOVED TO 300039
600420
MOVED TO 300039
600476
MOVED TO 300040
Clinical Synopsis for
600420
MOVED TO 300039
March 13, 1996
New Entries:
601120
CADHERIN-5; CDH5
601121
PLACENTAL GROWTH FACTOR; PIGF
601122
SEROTONIN 5-HT-2B RECEPTOR; HTR2B
601123
SIALYLTRANSFERASE 8; SIAT8
601124
SEMAPHORIN III/F; SEMA3F
601125
HEXOKINASE 2; HK2
Changed Entries:
103720
ALCOHOL DEHYDROGENASE-2; ADH2
115197
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
123000
CRANIOMETAPHYSEAL DYSPLASIA, DOMINANT TYPE
125310
DEMENTIA, HEREDITARY MULTI-INFARCT TYPE
125370
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
138251
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE A; GRINA
141500
HEMIPLEGIC MIGRAINE, FAMILIAL; MHP
154200
NAD-DEPENDENT MDH; MDH1
176916
PROTEIN PHOSPHATASE 2A, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB
181500
SCHIZOPHRENIA-2
182135
SEROTONIN 5-HT-2A RECEPTOR; HTR2A
189964
GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2
192240
VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF
216400
COCKAYNE SYNDROME, TYPE I; CKN1
259730
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS
300300
AGAMMAGLOBULINEMIA
300300
AGAMMAGLOBULINEMIA
301500
ANGIOKERATOMA, DIFFUSE
314690
XE169 GENE; XE169;
400001
SELECTED MOUSE cDNA ON Y, HUMAN HOMOLOG OF; SMCY
600025
KINESIN 2; KNS2
600056
MOVED TO 314690
600864
CASEIN KINASE 1, DELTA; CSNK1D
600864
CASEIN KINASE 1, DELTA; CSNK1D
600939
INTERLEUKIN-11 RECEPTOR, ALPHA; IL11RA
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
March 12, 1996
Changed Entries:
103500
ALBINISM-DEAFNESS OF TIETZ
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1a; CMT1A
134797
FIBRILLIN-1; FBN1
143110
HLA-F HISTOCOMPATIBILITY TYPE; HLAF
148820
KLEIN-WAARDENBURG SYNDROME
154700
MARFAN SYNDROME; MFS
180849
RUBINSTEIN SYNDROME
193500
WAARDENBURG SYNDROME; WS1
208900
ATAXIA-TELANGIECTASIA; AT
600392
RAD52, YEAST, HUMAN HOMOLOG OF; RAD52
600638
FIBROSIS, CONGENITAL, OF VERTICALLY ACTING EXTRAOCULAR MUSCLES
600947
HUNTINGTIN-ASSOCIATED PROTEIN; HAP1
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
March 11, 1996
New Entries:
601119
CLPP PROTEASE
Changed Entries:
104230
ALPHA-3-FUCOSYLTRANSFERASE; FCT3A; CD15
107820
ARGINYL-tRNA SYNTHETASE; RARS
109535
B-CELL ASSOCIATED MOLECULE CD40; CD40
113650
BRANCHIOOTORENAL DYSPLASIA
131230
ENDONEXIN II; ENX2
131240
ENDOTHELIN-1; EDN1; ET1
138970
COLONY-STIMULATING FACTOR-3; CSF3
141900
HEMOGLOBIN--BETA LOCUS; HBB
142946
HOLOPROSENCEPHALY, TYPE 4; HPE4
157170
MIDLINE CLEFT SYNDROME
162200
NEUROFIBROMATOSIS, TYPE I; NF1
167770
REGENERATING ISLET-DERIVED 1-ALPHA; REG1A
167771
PANCREATIC STONE PROTEIN, SECRETORY, 2; PSPS2
176797
PROMYELOCYTIC LEUKEMIA ZINC FINGER; PLZF
181500
SCHIZOPHRENIA-2
194550
ZINC FINGER PROTEIN-42; ZNF42
202700
AGRANULOCYTOSIS, INFANTILE GENETIC
236100
HOLOPROSENCEPHALY, FAMILIAL ALOBAR
236100
HOLOPROSENCEPHALY, FAMILIAL ALOBAR
301500
ANGIOKERATOMA, DIFFUSE
311770
PHOSPHATIDYLINOSITOL GLYCAN CLASS A; PIGA
600270
PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE
600379
MYELIN TRANSCRIPTION FACTOR 1; MYT1
600380
UBIQUITOUSLY EXPRESSED NUCLEAR RECEPTOR; UNR
600530
SOLUTE CARRIER FAMILY 9, MEMBER A2; SLC9A2
600531
SOLUTE CARRIER FAMILY 9, ISOFORM A4; SLC9A4
600892
SINGLE-MINDED DROSOPHILA, HUMAN HOMOLOG OF; SIM
601104
PROGRESSIVE SUPRANUCLEAR PALSY
March 10, 1996
New Entries:
601111
NADPH-FLAVIN REDUCTASE; FLR
601112
THIOREDOXIN REDUCTASE; TXNR
601113
HEAT SHOCK 70 PROTEIN 4; HSPA4
Changed Entries:
108725
ATHEROGENIC LIPOPROTEIN PHENOTYPE; ALP
159440
MYELIN PROTEIN ZERO; MPZ
166945
MEMBRANE COMPONENT, CHROMOSOME 17, SURFACE MARKER 2; M17S2
256731
CEROID-LIPOFUSCNOSIS, NEURONAL 5; CLN5
309550
MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28
516060
COMPLEX V, ATP SYNTHASE, SUBUNIT ATPase 6; MTATP6; ATP6
600019
CYTOCHROME b561; CYB561
600538
PEROXIDE REDUCTASE, THIOREDOXIN-DEPENDENT; TDPX1
600538
PEROXIDE REDUCTASE, THIOREDOXIN-DEPENDENT; TDPX1
600548
MORTALIN-2; MOT2
600735
INTERFERON INDUCIBLE PROTEIN, 35-KD; IFP35
600747
T-BOX PROTEIN 2; TBX2
March 9, 1996
New Entries:
601107
MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT
601108
INTERLEUKIN-1-ASSOCIATED KINASE; IRAK
601109
SEROTONIN 5-HT-6 RECEPTOR; HTR6
601110
CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IV
Changed Entries:
118425
CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1
121014
CONNEXIN 43 GAP JUNCTION PROTEIN; CX43
147421
INCLUSION BODY MYOSITIS; IBM
147450
SUPEROXIDE DISMUTASE-1; SOD1
156225
LAMININ, ALPHA 2; LAMA2
176260
POTASSIUM VOLTAGE-GATED CHANNEL, SHAKER-RELATED SUBFAMILY, MEMBER
176640
PRION PROTEIN; PRNP
181500
SCHIZOPHRENIA-2
186990
T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2
231670
GLUTARICACIDEMIA I
237500
HYPERBILIRUBINEMIA II
256730
CEROID-LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
260565
PEHO SYNDROME
304040
CONNEXIN 32 GAP JUNCTION PROTEIN; CX32
310200
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER
600555
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600556
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2
600556
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2
600557
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3
600558
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4
601007
LEPTIN RECEPTOR; OBR
601109
SEROTONIN 5-HT-6 RECEPTOR; HTR6
March 8, 1996
New Entries:
601103
MICROFIBRIL-ASSOCIATED GLYCOPROTEIN 2; MAGP2
Changed Entries:
102642
STEROL O-ACYLTRANSFERASE; SOAT
156790
MICROFIBRIL-ASSOCIATED PROTEIN 2; MFAP2
229300
FRIEDREICH ATAXIA; FRDA
300032
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
302800
CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED; CMTX1
601105
CATHEPSIN K; CTSK
March 7, 1996
Changed Entries:
104613
CHAPERONIN CONTAINING T-COMPLEX SUBUNIT 6; CCT6
104751
SERUM AMYLOID A, 2; SAA2
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
111300
BLOOD GROUP--MN LOCUS; MN
111740
BLOOD GROUP--Ss LOCUS; Ss
112267
BONE MORPHOGENETIC PROTEIN-7; BMP7
113810
BULLOUS PEMPHIGOID ANTIGEN-1; BPAG1; BP240
114761
CARBONIC ANHYDRASE V; CA V; CA5
114850
CARBOXYPEPTIDASE A1; CPA1
116805
CATENIN, ALPHA 1; CTNNA1
116957
CELLULAR PROTEIN p107; CP107
117700
CERULOPLASMIN; CP
120070
COLLAGEN, TYPE IV, ALPHA-3 CHAIN; COL4A3
120090
COLLAGEN, TYPE IV, ALPHA-2 CHAIN; COL4A2
120130
COLLAGEN, TYPE IV, ALPHA-1 CHAIN; COL4A1
120131
COLLAGEN, TYPE IV, ALPHA-4 CHAIN; COL4A4
120320
COLLAGEN, TYPE XII, ALPHA-1 CHAIN; COL12A1
126452
DOPAMINE RECEPTOR D4; DRD4
130050
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
164500
OLIVOPONTOCEREBELLAR ATROPHY III
164761
RET PROTO-ONCOGENE; RET
164875
ONCOGENE VAV; VAV
183090
SPINOCEREBELLAR ATROPHY II
186940
T-CELL ANTIGEN T4/LEU3; CD4
193300
VON HIPPEL-LINDAU SYNDROME; VHL
266200
PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE
300032
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
301040
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE
303630
COLLAGEN, TYPE IV, ALPHA-5 CHAIN; COL4A5
600160
CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
March 6, 1996
New Entries:
601104
PROGRESSIVE SUPRANUCLEAR PALSY
601105
CATHESPIN K; CTSK
601106
BB1 GENE; BB1
Changed Entries:
107741
APOLIPOPROTEIN E; APOE
107741
APOLIPOPROTEIN E; APOE
113705
BREAST CANCER, TYPE 1; BRCA1
116952
CELL DIVISION CYCLE 42; CDC42
119530
OROFACIAL CLEFT 1; OFC1
125310
DEMENTIA, HEREDITARY MULTI-INFARCT TYPE
130190
ELECTROENCEPHALOGRAPHIC PATTERNS; EEG
143100
HUNTINGTON DISEASE; HD
156225
LAMININ, ALPHA 2; LAMA2
159595
MYELOPROLIFERATIVE SYNDROME, TRANSIENT
160120
MYOKYMIA WITH PERIODIC ATAXIA
160900
DYSTROPHIA MYOTONICA; DM
162200
NEUROFIBROMATOSIS, TYPE I; NF1
162200
NEUROFIBROMATOSIS, TYPE I; NF1
162500
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
168600
PARKINSONISM
168600
PARKINSONISM
170500
PERIODIC PARALYSIS II
176943
PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14
183085
SPINOCEREBELLAR ATAXIA 3; SCA3
219800
CYSTINOSIS, EARLY-ONSET OR INFANTILE NEPHROPATHIC TYPE
229300
FRIEDREICH ATAXIA; FRDA; FA
236200
HOMOCYSTINURIA
236670
HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA
249100
MEDITERRANEAN FEVER, FAMILIAL; MEF
253220
MUCOPOLYSACCHARIDOSIS TYPE VII
253300
SPINAL MUSCULAR ATROPHY I; SMA I
277900
WILSON DISEASE; WND
300300
AGAMMAGLOBULINEMIA
600765
MKN28 KINASE
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
March 5, 1996
New Entries:
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
Changed Entries:
118200
CHARCOT-MARIE-TOOTH DISEASE; CMT1
118210
CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1a; CMT1A
118300
CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
145900
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
158580
MUSCULAR ATROPHY, DISTAL SPINAL, WITH VOCAL CORD PARALYSIS
160900
DYSTROPHIA MYOTONICA; DM
162100
NEURITIS WITH BRACHIAL PREDILECTION
162375
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING
170995
PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1
180630
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 5; DDX5
180710
RNA, U3 SMALL NUCLEAR; RNU3
214400
CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY
312080
PROTEOLIPID PROTEIN, MYELIN; PLP
600326
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600326
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600326
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 6; DDX6
600361
CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY WITH PYRAMIDAL FEATURES
600379
MYELIN TRANSCRIPTION FACTOR 1; MYT1
600630
UV-SENSITIVE SYNDROME; UVS
600882
CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, B; CMT2B
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
March 4, 1996
New Entries:
601102
EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2
Changed Entries:
110700
BLOOD GROUP--DUFFY SYSTEM; Fy
113811
COLLAGEN, TYPE XVII, ALPHA-1 POLYPEPTIDE; COL17A1
120110
COLLAGEN, TYPE X, ALPHA 1; COL10A1
120150
COLLAGEN, TYPE I, ALPHA-1 CHAIN; COL1A1
120160
COLLAGEN, TYPE I, ALPHA-2 POLYPEPTIDE; COL1A2
120327
MOVED TO 113811
120400
COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY
146880
IMMUNE RESPONSE ANTIGENS; HIa; DC1
147679
IL-1 RECEPTOR ANTAGONIST; IL1RN
152430
LONGEVITY
152690
THYROID AUTOANTIGEN 70 KD; G22P1
152690
THYROID AUTOANTIGEN 70 KD; G22P1
154700
MARFAN SYNDROME; MFS
155755
MELANOMA-ASTROCYTOMA SYNDROME
164810
V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS
172425
PHOSPHOLIPID TRANSFER PROTEIN; PLTP
184755
STEROL CARRIER PROTEIN-2; SCP2
188300
THYMIDINE KINASE, SOLUBLE; TK1
191092
TUBEROUS SCLEROSIS-2; TSC2
191100
TUBEROUS SCLEROSIS-1; TSC1
192090
CADHERIN 1; CDH1
194364
X-RAY-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER 5; XRCC5
222600
DIASTROPHIC DYSPLASIA; DTD
226650
EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
232300
GLYCOGEN STORAGE DISEASE II
245200
KRABBE DISEASE
264470
PSEUDONEONATAL ADRENOLEUKODYSTROPHY
276903
MYOSIN VIIA; MYO7A
300000
OPITZ G/BBB SYNDROME, X-LINKED
300011
ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE, INCLUDED; ATP7A
312080
PROTEOLIPID PROTEIN, MYELIN; PLP
424500
GONADOBLASTOMA; GBY
590050
TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1
600650
CARNITINE PALMITOYLTRANSFERASE II; CPT2
600717
COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600717
COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600717
COLLAGEN, TYPE XIX, ALPHA-1 POLYPEPTIDE; COL19A1
600972
ACHONDROGENESIS, TYPE IB
601064
BUTYRATE RESPONSE FACTOR 1, BRF1
Clinical Synopsis for
274800
THYROID HORMONOGENESIS, GENETIC DEFECT IN, IV
March 3, 1996
New Entries:
300038
NUCLEOTIDE RECEPTOR, URIDINE; NRU
601101
OSLER-RANDU-WEBER SYNDROME 3; ORW3
Changed Entries:
101000
NEUROFIBROMATOSIS, TYPE II
101200
ACROCEPHALOSYNDACTYLY TYPE I; ACS1
101600
ACROCEPHALOSYNDACTYLY TYPE V
101600
ACROCEPHALOSYNDACTYLY TYPE V; ACS5
106700
ANOMALOUS PULMONARY VENOUS RETURN; APVR
120140
ALPHA-1(II) COLLAGEN CHAIN; COL2A1
120140
COLLAGEN, TYPE II, ALPHA-1 CHAIN; COL2A1
139250
GROWTH HORMONE 1; GH1
147620
INTERLEUKIN-6; IL6
176943
PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14
178640
SURFACTANT-ASSOCIATED PROTEIN, PULMONARY-3; SFTP3
218030
CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
270400
SMITH-LEMLI-OPITZ SYNDROME
270400
SMITH-LEMLI-OPITZ SYNDROME
300000
OPITZ BBBG SYNDROME, TYPE I; BBBG1
304110
CRANIOFRONTONASAL DYSPLASIA; CFND
600160
CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
March 1, 1996
New Entries:
601099
SRC-LIKE ADAPTER; ALA
601100
STRESS70 PROTEIN CHAPERONE, MICROSOME-ASSOCIATED; STCH
Changed Entries:
114030
CAFE-AU-LAIT SPOTS, MULTIPLE; CALM
125480
DEPRESSIVE DISORDER
136131
FLAVIN-CONTAINING MONOOXYGENASE 2; FMO2
173110
PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1
191081
TRYPTASE, BETA; TPS2
191510
GENE UPSTREAM OF NRAS
203100
ALBINISM I
230450
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE
239200
HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSPH; NSHPT
305900
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
309200
MANIC-DEPRESSIVE PSYCHOSIS
309200
MANIC-DEPRESSIVE PSYCHOSIS
516060
COMPLEX V, ATP SYNTHASE, SUBUNIT ATPase 6; MTATP6; ATP6
530000
KEARNS-SAYRE SYNDROME; KSS
600380
UBIQUITOUSLY EXPRESSED NUCLEAR RECEPTOR; UNR
600483
FIBROBLAST GROWTH FACTOR-8; FGF8
600975
GLAUCOMA, PRIMARY CONGENITAL, TYPE B; GLC3B
601015
NIEMANN-PICK DISEASE, TYPE C2; NPC2
601099
SRC-LIKE ADAPTER; SLA
601100
STRESS70 PROTEIN CHAPERONE, MICROSOME-ASSOCIATED, p60; STCH
Disclaimer
|
Write to the Help Desk
|
Privacy Policy
NCBI
|
NLM
|
NIH